Header Logo

Connection

Kamyar Kalantar-Zadeh M.D. to Alkaline Phosphatase

Back to Details
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Alkaline Phosphatase.
Kamyar Kalantar-Zadeh M.D.
Connection Strength
6.271
Alkaline Phosphatase
  1. Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease. Curr Opin Nephrol Hypertens. 2020 01; 29(1):4-15.
    View in: PubMed
    Score: 0.644
  2. Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease. Atherosclerosis. 2019 11; 290:59-65.
    View in: PubMed
    Score: 0.631
  3. Apabetalone Mediated Epigenetic Modulation is Associated with Favorable Kidney Function and Alkaline Phosphatase Profile in Patients with Chronic Kidney Disease. Kidney Blood Press Res. 2018; 43(2):449-457.
    View in: PubMed
    Score: 0.569
  4. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis. Nephrol Dial Transplant. 2018 02 01; 33(2):264-273.
    View in: PubMed
    Score: 0.564
  5. Towards the revival of alkaline phosphatase for the management of bone disease, mortality and hip fractures. Nephrol Dial Transplant. 2014 Aug; 29(8):1450-2.
    View in: PubMed
    Score: 0.434
  6. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit Dial Int. 2014 Nov-Dec; 34(7):732-48.
    View in: PubMed
    Score: 0.425
  7. Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients. Hemodial Int. 2010 Apr; 14(2):182-92.
    View in: PubMed
    Score: 0.327
  8. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol Dial Transplant. 2010 Sep; 25(9):3003-11.
    View in: PubMed
    Score: 0.327
  9. Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2009 Jun; 4(6):1106-14.
    View in: PubMed
    Score: 0.308
  10. Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2009 Mar; 4(3):673-9.
    View in: PubMed
    Score: 0.304
  11. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol. 2008 Nov; 19(11):2193-203.
    View in: PubMed
    Score: 0.292
  12. Seasonal variation of serum 25-hydroxyvitamin D and parameters of bone and mineral disorder in dialysis patients. Bone. 2019 07; 124:158-165.
    View in: PubMed
    Score: 0.152
  13. Apabetalone downregulates factors and pathways associated with vascular calcification. Atherosclerosis. 2019 01; 280:75-84.
    View in: PubMed
    Score: 0.149
  14. Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD. Nat Rev Nephrol. 2017 07; 13(7):429-442.
    View in: PubMed
    Score: 0.134
  15. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function. Clin J Am Soc Nephrol. 2017 Jul 07; 12(7):1118-1127.
    View in: PubMed
    Score: 0.134
  16. Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients. J Ren Nutr. 2016 07; 26(4):265-9.
    View in: PubMed
    Score: 0.124
  17. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients. Am J Nephrol. 2016; 43(2):85-96.
    View in: PubMed
    Score: 0.124
  18. Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease? Hemodial Int. 2014 Oct; 18(4):720-4.
    View in: PubMed
    Score: 0.112
  19. Impact of age on survival predictability of bone turnover markers in hemodialysis patients. Nephrol Dial Transplant. 2013 Oct; 28(10):2535-45.
    View in: PubMed
    Score: 0.103
  20. Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant. 2013 Jun; 28(6):1516-25.
    View in: PubMed
    Score: 0.100
  21. Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients. J Ren Nutr. 2011 Jan; 21(1):100-4.
    View in: PubMed
    Score: 0.086
  22. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl. 2010 Aug; (117):S10-21.
    View in: PubMed
    Score: 0.084
  23. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr. 2010 Jul; 20(4):243-54.
    View in: PubMed
    Score: 0.081
  24. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006 Aug; 70(4):771-80.
    View in: PubMed
    Score: 0.063
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.